Citation: M. Farncombe et S. Chater, CLINICAL-APPLICATION OF NEBULIZED OPIOIDS FOR TREATMENT OF DYSPNEA INPATIENTS WITH MALIGNANT DISEASE, Supportive care in cancer, 2(3), 1994, pp. 184-187
Citation: M. Farncombe et S. Chater, CASE-STUDIES OUTLINING USE OF NEBULIZED MORPHINE FOR PATIENTS WITH END-STAGE CHRONIC LUNG AND CARDIAC DISEASE, Journal of pain and symptom management, 8(4), 1993, pp. 221-225